(2026). Adjunctive Dulaglutide in Relapsing–Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial. Neurology and Therapy.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Adjunctive Dulaglutide in Relapsing–Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial."
Neurology and Therapy 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Adjunctive Dulaglutide in Relapsing–Remitting Multiple Sclerosis: A Randomized Open-Label Proof-of-Concept Trial."
Neurology and Therapy, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.